23andme company stock.

The consumer DNA testing company 23andMe Inc. announced Thursday plans to go public. The company will be listed under the VGAC ticker on the New York Stock Exchange, before changing to the ME ...SOUTH SAN FRANCISCO, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company with a mission to help people access, understand, and benefit from the human genome, today reported its financial results for the fourth quarter (“Q4”) and full …Industry. Biotechnology. No executives to display. Corporate headquarters. --, --. Find real-time ME - 23andMe Holding Co. stock quotes, company profile, news and forecasts from CNN Business.Q4 Earnings Releases. 23andMe's FY2023 4th Quarter Earnings Call. 23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results. Form 10-K.In 2019, the company brought in $441 million in revenue, with consumer services accounting for 96% of sales. However, its forecast for this year amounts to just $243.5 million in sales. 23andMe is ...

With the rapid growth of the electric vehicle (EV) industry, investing in EV battery stocks has become an attractive option for many investors. As more countries and companies commit to reducing their carbon footprint, the demand for electr...Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock.peopleimages/Getty images. DNA testing company 23andMe has sold the rights to a new drug that it has developed using its customers’ data. It is the first time the company has signed a deal to ...

Nov 15, 2021 · Things got even worse today, when investors responded to a downgrade of 23andMe stock by a Citigroup analyst -- by selling off the stock by 10.1% (as of 11:30 a.m. EST). Image source: Getty Images ...

ME Earnings Date and Information. 23andMe last issued its quarterly earnings data on November 8th, 2023. The reported ($0.16) EPS for the quarter. The firm earned $50 million during the quarter, compared to the consensus estimate of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year ( ($0.73) …Dec 4, 2023 11:59 AM PST. By Jon Swartz. Company says it believes breach was the result of customers recycling passwords. DNA-testing company 23andMe confirmed Monday that information about 6.9 ...Nov 20, 2023 · Website. 2006. 758. Anne Wojcicki. https://www.23andme.com. 23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers’ genetic ... 23andMe to Report FY2024 Second Quarter Financial Results. SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced …Biotech Acquisition Company - Warrant exercisable for one share at $11.50 per share: Shell Companies: $11.50: $0.01: $10.15: $0: 414,459: BIOT: Biotech Acquisition Company - Class A: Common stocks: Analyze: BITE+: Bite Acquisition Corp. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50: Shell ...

About this app. Explore your DNA with 23andMe. Discover how your DNA connects you to 2000+ geographic regions around the world. Gain insights into your health, traits, and more. • Ancestry + Traits Service includes Ancestry Composition — covering 2000+ geographic regions — and 30+ Trait reports such as Ability to Match Musical Pitch ...

VGAC stock spiked above $16 in February 2021 on optimism over the 23andMe merger. However, it has fallen sharply in 2022 and hit an all-time low of $2.12, while the SPAC IPO price was $10.

Investor Relations NASDAQ GS: ME $0.93 +0.0507 (+5.77%) Data Provided by Refinitiv. Minimum 15 minutes delayed. Corporate Profile 23andMe is a leading consumer genetics and research company. Founded in 2006, our mission is to help people access, understand, and benefit from the human genome.23andMe Stock Earnings. The value each ME share was expected to gain vs. the value that each ME share actually gained. 23andMe ( ME) reported Q3 2023 earnings per share (EPS) of -$0.16, missing estimates of -$0.14 by 12.80%. In the same quarter last year, 23andMe 's earnings per share (EPS) was -$0.15. 23andMe is expected to release next ...Genetic testing company 23andMe announced on Friday that hackers accessed around 14,000 customer accounts in the company’s recent data breach. …Shares of 23andMe ( ME -0.66%) rose more than 9% on Tuesday. The stock, which closed at $11.36 on Monday, opened at $11.40 and rose as high as $12.44 at midday on Tuesday. The stock has been as ...SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, reported its financial results for the first quarter (Q1) of fiscal year 2024 (FY2024), which ended June 30, 2023. 23andMe is the only company with multiple U.S. Food and Drug ...

23andMe is known for its ancestry DNA genetic testing service, but the company faces disruption from whole genome sequencing. Read why I rate ME stock a sell.Discover historical prices for ME stock on Yahoo Finance. View daily, weekly or monthly format back to when 23andMe Holding Co. stock was issued.4 Aug 2021 ... After raising $600 million and being valued at $3.5 billion, CNBC reported that 23andMe's shares rose by 21% during its first day of trading.23andMe (ME) stock gained ~11% on Monday after announcing that hackers accessed only 0.1% of customer accounts during a recent data breach. Read more here.Contact Us U.S. markets open in 6 hours 16 minutes Dow Futures Nasdaq Futures Russell 2000 Futures +1.80(+0.10%) Crude Oil +0.66 Gold 2,065.00 -2.10(-0.10%) 23andMe Holding Co. (ME) NasdaqGS -...

Things got even worse today, when investors responded to a downgrade of 23andMe stock by a Citigroup analyst -- by selling off the stock by 10.1% ... The company's therapeutics division, on the ...I understand that I may withdraw my consent and unsubscribe at any time. Get two Health + Ancestry Services for $239; third Health + Ancestry Service is $129; each additional Health + Ancestry Service is $299. Offer ends Nov 27. Entry of your email address is not necessary to redeem the offer. Shop now. Limit 3.

Silicon Valley DNA testing company 23andMe, which has raised nearly $800 million in funding and was last valued at $2.5 billion, cut 14% of its workforce last week. The cause is a slowdown in ...FY2022 First Quarter Financial Results. Total revenue was $59 million for the quarter ended June 30, 2021, representing an increase of $11 million or 23%, year over year. This revenue growth was primarily due to higher Personal Genome Service (PGS) kit sales, which resulted from increased marketing spending and growth in consumer demand.Feb 8, 2023 · SOUTH SAN FRANCISCO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, today reported its financial results for the third quarter (Q3) of its fiscal year 2023 (FY2023 ... Shares of consumer genetics company 23andMe rose 21% in their trading debut Thursday, after the provider of home DNA test kits went public via a merger with Richard Branson’s special-purpose ...Nov 30, 2023 · According to 3 analysts, the average rating for ME stock is "Strong Buy." The 12-month stock price forecast is $4.92, which is an increase of 455.87% from the latest price. These surveys are proving valuable to drug investigators. This year the company found genetic variations strongly linked to whether customers consider themselves early risers, offering a clue ...Richard Branson’s company is joining forces with 23andMe through what is known as a ‘blank-check company’. ... after which the company will begin trading on the New York stock exchange under ...Feb 4, 2021 · SUNNYVALE, CALIFORNIA & NEW YORK, NY – February 4, 2021 – 23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, announced today that they have entered into a definitive merger agreement. Upon completion of the transaction ... Founded in 2006 and headquartered in Sunnyvale, California, 23andMe is a leading consumer genetics and research company. 23andMe’s mission is to help people access, understand, and benefit from ...The testing frenzy is creating two superpowers—Ancestry of Lehi, Utah, and 23andMe of Mountain View, California. These privately held companies now have some of the world’s largest collections ...

Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock. The acquisition is expected to close by the end of 2021. The acquisition adds Lemonaid Health’s innovative telemedicine and prescription drug ...

Genetic testing company 23andMe announced on Friday that hackers accessed around 14,000 customer accounts in the company’s recent data breach. published Friday, the company said that, based on ...

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, today reported its financial results for the third quarter (Q3) of its fiscal year 2023 (FY2023 ...Aug 8, 2022 · Shares of genetic data healthcare company 23andMe (ME-0.86%) jumped higher on Monday morning, as did many other beaten-down stocks. By noon ET, 23andMe stock was up 16% and trading volume was ... SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ME (23andMe), a leading genetic health and biopharmaceutical company, today launched 23andMe+ Total Health, its ...Funding. 23andMe has raised a total of. $1.1B. in funding over 19 rounds. Their latest funding was raised on Jun 17, 2021 from a Post-IPO Equity round. 23andMe is registered under the ticker NASDAQ:ME . 23andMe is funded by 39 investors. Richard Branson and Altimeter Capital are the most recent investors. 23andMe has a post-money valuation in ...The combined company is owned by 23andMe Holding Co. Richard Branson and CEO Anne Wojcicki are major stakeholders. Other investors include Altimeter Capital, Fidelity, and Foresite Capital. Since the company was founded in 2006, it has been involved in multiple funding rounds. There were at least 60 investors in 2020 before the …The company was named by MIT Technology Review in its “50 Smartest Companies, 2017” list, and featured as Fast Company's #2 Most Innovative Health Company in 2018. 23andMe has millions of customers worldwide, with over 80 percent of customers consented to participate in research. 23andMe, Inc. is located in Mountain …DNA testing company 23andMe has released further details surrounding an October data breach, where user profile information had been accessed and downloaded at the hands of a threat actor.. On Oct ...23andMe is known for its ancestry DNA genetic testing service, but the company faces disruption from whole genome sequencing. Read why I rate ME stock a sell.Mar 1, 2023 · I would rate 23andMe a buy rating. Although the stock price is a bit shaky and volatile, when thinking about the long term, the company has high potential to be big in the genomics testing space ... Aug 8, 2022 · Shares of genetic data healthcare company 23andMe (ME-0.86%) jumped higher on Monday morning, as did many other beaten-down stocks. By noon ET, 23andMe stock was up 16% and trading volume was ... 1 Sept 2023 ... 23andMe (ME) shares are rising after the personal genetics company was given FDA approval on testing for cancer variants in customers.Feb 4, 2021 · 23andMe is merging with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson, to go public. The deal values the consumer genetic testing company at $3 ...

December 4, 2023 at 4:46 PM. Tiffany Hagler-Geard. Genetic testing company 23andMe said Monday that hackers were able to access the data of about 6.9 million people, far more than the company ...WuXi has a less than 1 percent investment in 23andMe and has never received any customer data, Jacquie Cooke Haggarty, the company’s deputy general counsel, said in a statement.Company Overview. 23andMe is a genomics and biotechnology company that provides health reports to consumers by analyzing their DNA. ... the company's stock price has performed poorly in the recent ...Instagram:https://instagram. health insurance companies in arizonainverted yieldalexandria real estate equities incabbvie stock dividends 23andMe stock closed Monday at $0.82, less than a third of its price 12 months ago. Like many companies that went public as part of the boom in SPAC financings, its shares have struggled.AA. Follow us. Genetic testing company 23andMe announced a recent data breach where hackers accessed around 14,000 customer accounts. The stolen data generally included ancestry information and ... austin hankwitzjepi payout date All Those 23andMe Spit Tests Were Part of a Bigger Plan. CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone ... how do funded accounts work Discover historical prices for ME stock on Yahoo Finance. View daily, weekly or monthly format back to when 23andMe Holding Co. stock was issued.Mar 1, 2023 · I would rate 23andMe a buy rating. Although the stock price is a bit shaky and volatile, when thinking about the long term, the company has high potential to be big in the genomics testing space ... 9.31%. Overview. Complete 23andMe Holding Co. stock information by Barron's. View real-time ME stock price and news, along with industry-best analysis.